Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.

Показать другие версии (1)

We examined the prognostic value of programmed cell death-1 (PD-1) and its ligand (PD-L1) together with CD8+ tumor-infiltrating lymphocytes (TILs) and FOXP3+ Tregs in resectable pancreatic ductal adenocarcinoma (PDAC) samples treated with adjuvant chemotherapy. Whole-mount FFPE tissue sections from...

Полное описание

Библиографические подробности
Главные авторы:	Diana, A, Wang, L, D'Costa, Z, Allen, P, Azad, A, Silva, M, Soonawalla, Z, Liu, S, McKenna, W, Muschel, R, Fokas, E
Формат:	Journal article
Язык:	English
Опубликовано:	Impact Journals 2016

Схожие документы

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
по: Diana, A, и др.
Опубликовано: (2016)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
по: Wang, L, и др.
Опубликовано: (2015)

PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
по: Dushek, O, и др.
Опубликовано: (2016)

PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
по: Abul Azad, и др.
Опубликовано: (2016-12-01)

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
по: Tina Daunke, и др.
Опубликовано: (2023-06-01)

High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma
по: Damián Sánchez-Ramírez, и др.
Опубликовано: (2022-02-01)

Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.
по: Fokas, E, и др.
Опубликовано: (2015)

Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
по: Qian Zhu, и др.
Опубликовано: (2022-04-01)

Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
по: Azaz Ahmed, и др.
Опубликовано: (2022-09-01)

Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
по: Ole Helm, и др.
Опубликовано: (2014-01-01)

The Desmoplastic Stroma Plays an Essential Role in the Accumulation and Modulation of Infiltrated Immune Cells in Pancreatic Adenocarcinoma
по: Vegard Tjomsland, и др.
Опубликовано: (2011-01-01)

Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma
по: Adam L. Burrack, и др.
Опубликовано: (2019-08-01)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
по: Florian Gebauer, и др.
Опубликовано: (2017-01-01)

The Importance of Stroma and Stromal SMA Expression in Pancreatic Ductal Adenocarcinoma
по: Gamze AKBAS, и др.
Опубликовано: (2024-09-01)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
по: Yue Zhang, и др.
Опубликовано: (2022-05-01)

The T cell architecture of pancreatic ductal adenocarcinoma
по: Sivakumar, S, и др.
Опубликовано: (2019)

The T-cell architecture of pancreatic ductal adenocarcinoma
по: Sivakumar, S, и др.
Опубликовано: (2019)

Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
по: Sophie Liot, и др.
Опубликовано: (2021-04-01)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
по: Dajia Liu, и др.
Опубликовано: (2020-10-01)

The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
по: Mei Lu, и др.
Опубликовано: (2023-07-01)

GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma
по: Juan Li, и др.
Опубликовано: (2020-02-01)

Bispecific immune molecule PD1-IL2v: a new therapeutic strategy for pancreatic ductal adenocarcinoma
по: Yuan Gao, и др.
Опубликовано: (2023-10-01)

Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
по: Panagiotis Balermpas, и др.
Опубликовано: (2017-03-01)

Case report: Ductal eccrine adenocarcinoma with fibromyxoid stroma
по: Kyle Mitts, DO, и др.
Опубликовано: (2017-09-01)

Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
по: Maria João Amaral, и др.
Опубликовано: (2023-02-01)

Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma
по: Jiahong Jiang, и др.
Опубликовано: (2021-10-01)

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
по: Bryn Golesworthy, и др.
Опубликовано: (2022-04-01)

PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay
по: Xiaolong Liang, и др.
Опубликовано: (2018-01-01)

3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma
по: Xinyuan Liu, и др.
Опубликовано: (2021-07-01)

Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients with Pancreatic Ductal Adenocarcinoma (PDAC)
по: Alina Constantin, и др.
Опубликовано: (2022-01-01)

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
по: Silje Beckinger, и др.
Опубликовано: (2023-05-01)

CT Radiomics and Machine-Learning Models for Predicting Tumor-Stroma Ratio in Patients With Pancreatic Ductal Adenocarcinoma
по: Yinghao Meng, и др.
Опубликовано: (2021-11-01)

Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control
по: Steffen M. Heckl, и др.
Опубликовано: (2021-06-01)

Gemcitabine-induced TIMP1 attenuates therapy response and promotes tumor growth and liver metastasis in pancreatic cancer
по: D'Costa, Z, и др.
Опубликовано: (2017)

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
по: Yiyin Zhang, и др.
Опубликовано: (2019-08-01)

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
по: Benjamin Bian, и др.
Опубликовано: (2019-04-01)

Tumor–stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma
по: Dong Wang, и др.
Опубликовано: (2023-05-01)

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer
по: Li Wang, и др.
Опубликовано: (2018-08-01)

Feasibility and effectiveness of automatic deep learning network and radiomics models for differentiating tumor stroma ratio in pancreatic ductal adenocarcinoma
по: Hongfan Liao, и др.
Опубликовано: (2023-12-01)

Pancreatic and duodenal homeobox-1 in pancreatic ductal adenocarcinoma and diabetes mellitus
по: Zhen-Chu Tang, и др.
Опубликовано: (2020-02-01)